Learning Drug Interactions Flashcards

1
Q

Pharmacodynamics definition

A

Effect drug has on the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drugs that have similar end effects through different mechanisms/receptors can cause _____ effects

A

additive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Benzodiazepines and opioids risk

A

BBW
Sedation, respiratory depression, coma, death
Reserve for use in patients for whom alternative treatment is inadequate
Limit dose and duration to minimum required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is synergism?

A

When the effect from two drugs taken in combination is greater than the effect from adding the two individual effects together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacokinetic definition

A

effect the body has on a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

4 parts of pharmacokinetics

A

Absorption
Distribution
Metabolism
Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drugs with polyvalent cations or other binding properties should be separated from what medications?

A

quinolones, tetracyclines, levothyroxine, oral bisphosphonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where are CYP enzymes primarily located?

A

In the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Common prodrugs

A
Capecitabine
Copidogrel
Codeine
Colistimethane
Cortisone
Enalapril
Famciclovir
Fosphenytoin
Isavuconazonium sulfate
Levodopa
Lisdexamfetamine
Prednisone
Primidone
Tramadol
Valacyclovir
Valganciclovir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Codeine safety consideration with CYP enzymes

A

Ultra-rapid metabolizers of CYP2D6 - can lead to toxicity - do not use in these patients
Poor analgesia with poor metabolizers of CYP2D6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clopidogrel safety considerations with CYP enzymes

A

Do not use with CYP2C19 inhibitors (omeprazole and esomeprazole) - block conversion to active form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Major CYP inhibitors

A
G-PACMAN
G - grapefruit
P - protease inhibitors
A - azole antifungals
C - cyclosporine, cimetidine, cibicistat
M - macroides (clari and ery, but not azithromycin)
A - Amiodarone
N - non-DHP CCBs (diltizem and verapamil)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Major CYP inducers

A
CROSS PP
C - Carbamazepine
R - Rifampin, rifabutin, rifapentine
O - Oxcarbazepine
S - Smoking
S - St. John's Wort
P - Phenytoin
P - Phenobarbital
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How long for CYP inhibitor effect to go away once stopped? Inducer effect?

A

Inhibitor effect goes away quickly once d/c

Inducer effect goes away 2-4 weeks once d/c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do P-gp pumps work?

A

Transport drugs and their metabolites out of the body by pumping them into the gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What effect do P-gp inhibitors have?

A

Increase absorption of P-gp substrates (less drug is pumped into the gut) and the substrate drug level will increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

P-gp substrates

A

Anticoagulants (apixaban, rivaroxaban)
CV drugs (digoxin, diltiazem, verapamil)
Immunosuppressants (cyclosporine, tacrolimus)
HCV drugs (ombitasvir, paritaprevir, dasabuvir)
Others (colchicine, saxagliptin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

P-gp inducers

A
Carbamazepine
Phenobarbital
Phenytoin
Rifampin
St. John's wort
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

P-gp inhibitors

A

Anti-infectives (clarithromycin, itra and posaconazole)
CV drugs (amiodarone, diltiazem, verapamil, carvedilol)
HIV drugs (cobicistat, ritonavir)
HCV drugs (ledipasvir, paritaprevir)
Others (cyclosporine, ticagrelor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Amiodarone and Warfarin interaction risk and action that should be taken by pharmacist

A

Risk: amiodarone inhibits CYP2C9 which metabolizes warfarin - increased INR and bleeding risk

If adding amiodarone after warfarin, decrease warfarin by 30-50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Amiodarone and digoxin interaction risk and action that should be taken by pharmacist

A

Amiodarone inhibits P-gp; digoxin is P-gp substrate
Decreased dig excretion, increases ADRs/toxicity

Additive bradycardia, arrhythmia and fatality when taken together

Decrease dig dose 50% when adding amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Digoxin and loop diuretic interaction risk

A

Loops decrease K, Mg, Ca, and Na

Risk of dig toxicity increases with low K and Mg and high Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Drugs that decrease HR interaction risk

A

Additive effects with medications including amiodarone, digoxin, beta-blockers, clonidine, dexmedetomidine, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Statin and strop CYP3A4 inhibitors (G-PAKMAN) interaction risk and action that should be taken by pharmacist

A

Increase levels of CYP substrates: lovastatin, simvastatin, atorvastatin, increased myopathy risk, rhabdo, and ARF
Simva and lova are contraindicated - recommend pitava, prava, or rosuva b/c not metabolized by CYP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Warfarin and CYP2C9 inhibitors and inducers interaction risk
Increase levels of warfarin with 2C9 inhibitors Decrease levels of warfarin with 2C9 inducers
26
CYP3A4 inhibitors and CYP3A4 substrates interaction risk and action that should be taken by pharmacist
Decrease CYP3A4 substrate metabolism causing increased drug concentration and increased ADR/toxicity Do not use CYP3A4 inhibitor with opioid metabolized by 3A4 (fentanyl, hydrocodone, oxycodone, methadone)
27
Which medications specifically include instructions to not take with grapefruit juice?
``` Amiodarone Simvastatin Lvoastatin Nifedipine Tacrolimus ```
28
Valproate and lamotrigine interaction risk and action that should be taken by pharmacist
Valproate decreases lamotrigine metabolism, increasing lamotrigine levels and risk of serious skin reactions
29
Monoamine oxidase inhibitors (MAOi) + drugs that increase Epi, NE, and DA + drugs that increase serotonin interaction risk and action that should be taken by pharmacist
MAOi increase Epi, NE, DA, and 5-HT which can cause HTN crisis and serotonin syndrome Do not use together Use a 2 week washout period between serotonergic drugs and another antidepressnat
30
MAOi + tyramine risk foods/drinks interaction risk and
MAO metabolizes tyramine, if blocked, tyramine causes increase in NE with risk of HTN crisis Do not eat foods rich in tyramine
31
CYP2D6 inhibitors (amiodarone, fluoxetine, paroxetine, fluvoxamine) and CYP2D6 substrates interaction risk and action that should be taken by pharmacist
Decreased metabolism and increased ADRs and toxicity | Avoid using together or decrease dose of the substrate
32
CYP3A4, P-gp inhibitors + calcineurin inhibitors (tacrolimus, cyclosphorine) or mTOR kinase inhibirors (sirolimus, everolimus) interaction risk and action that should be taken by pharmacist
Decreased drug metabolism, increased ADRs/toxicity, including blood pressure, nephrotoxicity, metabolic syndrome and other adverse effects Avoid using together or decrease dose of CNI or mTOR kinase inhibitor
33
Phenytoin, phenobarbital, primidone, carbamazepine, oxcarbazapine + other drugs metabolized by CYP enzymeinteraction risk and action that should be taken by pharmacist
Increased substrate metabolism will cause decreased drug levels Monitor drug levels, consider increasing the dose of the substrate drug
34
Rifampin and cyp and P-gp substrates interaction risk and action that should be taken by pharmacist
Concentration of substrate drugs will greatly decrease | Monitor drug levels, increase dose of substrate drug level if necessary
35
CYP3A4 inducers + opioids that are substrates of CYP3A4 (fentanyl, hydrocodone, oxycodone, methadone) interaction risk and action that should be taken by pharmacist
Increased metabolism adn decreased opioid concentration | Assess pain level
36
CYP2D6 ultra-rapid metabolizers + prodrugs (codeine, tramadol) interaction risk and action that should be taken by pharmacist
Prodrug is converted to active drug more rapidly Increased active drug concentration which can cause toxicity/risk and possible fatality Do not use codeine or tramadol in patients <12 or in breast-feeding mother unless it is known she is not 2D6 UM
37
CYP3A4, P-gp inducers + Calcineurin inhibitors (CNIs) (tacrolimus, cyclosporine) or mTOR kinase inhibitors (sirolimus, everolimus) interaction risk and action that should be taken by pharmacist
Increased drug metabolism, decreased transplant drug levels and increased risk of rejection Avoid use together; monitor transplant drug level for efficacy
38
Smoking + some antipsychotics, antidepressants, hypnotics, anxiolytics, caffeine, theophylline, warfarin
Smokers who quit: drug concentrations will increase and cause toxicity Current smokers: decreased drug concentrations
39
What CYP enzyme does smoking induce?
1A2
40
What medications have additive serotonergic effects
``` Antidepressants (SSRIs, SNRIs, TCAs, mirtazapine, trazodone) MAOi Buspirone Dextromethorphan Dihydroergotamine Lithium Lorcaserin Opioids Metoclopramide Triptans Natural products (St. John's wort) Tegaserod ```
41
How long is the washout period for fluoxetine and why is it longer than other medications?
5 weeks | Longer half-life
42
What medications have additive bleeding risk side effect
``` Anticoagulants Antiplatelets NSAIDs SSRIs, SNRIs Natural products (Garlic, ginger, ginkgo, biloba, ginseng, and glucosamine, vitamin E, willow bark, fish oils (high doses) ```
43
What medications have risk of hyperkalemia?
Spironolactone, eplerenone Renin-Angiotensin-Aldosterone Drugs Amiloride, triamterene, salt substitutes (KCl), calcineurin inhibitors, canagliflozin, bactrim, and drospirenone-containing oral contraceptives
44
What medications have increased risk of QT prolongation
``` Antiarrhythmics (amiodarone, dofetilide, dronedarone, ibutilide, sotalol) Antibiotics/antifungals Antidepressants Antipsychotics (most) Antiemetics Donepezil, fingolimod, methadone ```
45
What dose of citalopram and escitalopram should not be exceeded in patients >60 years old and why
Citalopram 40mg/d Escitalopram 20mg/d Increased risk of QT prolongation and torsades
46
What medications have additive ototoxicity effects
``` AG Cisplatin Loop diuretics Salicylates Vancomycin ```
47
What medications have additive nephrotoxicity effects
``` AG, amphotericin B, polymyxins, vancomycin Cisplatin CNI Loop diuretics NSAIDs Radiographic-contrast dye ```
48
What medications have additive anticholinergic effects
Paroxetine, TCA, first gen antipsychotics Sedating antihistamine Atropine, belladona, dicyclomine, meclizine Benztropine, trihexyphenidyl Muscle relaxants Overactive bladder antimuscarinics
49
What medications have additive hypotension/orthostasis effects
PDE-5 inhibitors CYP3A4 inhibitors Nitrates Alpha-1 blockers
50
What medications are CYP3A4 substrates?
Analgesics (fentanyl, hydrocodone, methadone, oxycodone Anticoagulants (apixaban, rivaroxaban, R-warfarin) Immunosuppresants Statins (atorva, lova, simva) HIV drugs PDE-5 inhibitors Ethinyl estradiol
51
What medications are CYP3A4 inducers
``` Carbamazepine Rifampain Oxcarbamazepine Smoking St John's wort Phenobarbital Phenytoin ```
52
What medications are CYP3A4 inhibitors
Clarithromycin, erytromycin, azole antifungals, amiodarone, diltiazem, verapamil, cobicistat, protease inhibitors, ritonavir, cyclosporine, grapefruit juice
53
What medications are CYP1A2 substrates
Theophylline | R-warfarin
54
What medications are CYP1A2 inducers
``` Carbamazepine Phenobarbital Phenytoin Rifampin Smoking St. John's wort ```
55
What medications are CYP1A2 inhibitors
Ciprofloxacin | Fluvoxamine
56
What medications are CYP2C8 substrates
``` Amiodarone Dasabuvir Pioglitazone Repaglinide Rosiglitazone ```
57
What medications are CYP2C8 inducers
Phenytoin | Rifampin
58
What medications are CYP2C8 inhibitors
Amiodarone, atazanavir, clopidogrel, gemfibrozil, ketoconazole, bactrim, ritonavir
59
What medications are CYP2C9 substrates
``` S-warfarin Carvedilol Celecoxib Diazepam Diclofenc, meloxicam Glyburide, glipizide ```
60
What medications are CYP2C9 inducers
``` Carbamazepine PHenobarbital Phenytoin Rifampin Smoking St. John's wort ```
61
What medications are CYP2C9 inhibitors
Amiodarone Fluconazole Metronidazole Bactrim
62
What medications are CYP2C19 substrates
Clopidogrel
63
What medications are CYP2C19 inducer
Carbamazepine Phenobarbital Phenytoin Rifampin
64
What medications are CYP2C19 inhibitor
Esomeprazole | Omeprazole
65
What medications are CYP2D6 substrates
Codeine, meperidine, tramadol, tamoxifen
66
What medications are CYP2D6 inducers
None!!! | Patients can be ultra-rapid metabolizer
67
What medications are CYP2D6 inhibitors
Fluoxetine | Paroxetine